- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
BUHLMANN News
BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BÜHLMANN fCAL turbo and fPELA turbo Assays
Amherst NH, September 2024- BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased ...
AMLI 2024 Recap for BUHLMANN Diagnostics Corp
Key Highlights BUHLMANN Diagnostics Corp proudly participated in the 37th Annual Meeting of the Association of Medical Laboratory Immunologists (AMLI) ...
BUHLMANN Diagnostics Corp’s ADLM 2024 Recap
Key Highlights We are thrilled to share the highlights of our successful participation in the Association for Diagnostics and Laboratory ...
BUHLMANN Diagnostics Corp Recap from DDW 2024
Key Highlights BUHLMANN Diagnostics Corp is excited to share highlights from our participation at Digestive Disease Week (DDW) 2024, held ...
CALEX Cap Updates- Extended Stability, Training Video & CALEX Cap 4.0
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN fPELA® turbo is FDA ...
Visit BUHLMANN @ AMLI 2024 (LIVE)
AMLI 2024 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line ...
Visit BUHLMANN at ADLM 2024 (formerly AACC)
ADLM 2024 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the ...
Visit BUHLMANN at DDW 2024
Assays Offerings Assays Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United ...
